Platelet-mediated hemostatic processes

Platelet-mediated hemostatic processes encompass the physiological sequence of events—adhesion, activation, and aggregation—that result in the formation of a platelet plug to arrest bleeding following vascular injury (StatPearls, 2023). Upon vessel wall damage, platelets adhere to subendothelial collagen via von Willebrand factor and undergo a shape change, releasing agonists like ADP and thromboxane A2 that recruit additional platelets (NIH, 2022). While vital for survival, the dysregulation of these processes can lead to arterial thrombosis, the underlying cause of myocardial infarction and ischemic stroke (PubMed, 2021). Therapeutic intervention typically involves antiplatelet drugs that target specific receptors or enzymes within this pathway, such as P2Y12 antagonists or COX-1 inhibitors. The clinical utility of affecting these processes is high in cardiovascular medicine, though it requires careful management to avoid life-threatening bleeding complications.

Other names

Platelet activationPlatelet aggregationPrimary hemostasisHemostatic plug formation

Inhibition of platelet aggregation through various molecular targets including COX-1, P2Y12 receptors, and Glycoprotein IIb/IIIa receptors to prevent thrombus formation.